Tennant Company — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024. Unaudited results; dollar amounts in millions except per-share data.
Business context and results
Tennant designs, manufactures and sells floor-cleaning equipment, parts and consumables, service and related solutions through direct sales and distributors. Net sales rose 1.7% to $311.0 million. Organic growth was 0.9%, comprising 4.6% price and a 3.7% volume decline; acquisitions contributed 0.3% and foreign exchange 0.5%.
- Americas sales increased 5.5% to $215.6 million. EMEA sales declined 6.5% to $76.8 million; APAC sales declined 3.6% to $18.6 million.
- Equipment sales rose to $189.8 million from $186.4 million; parts and consumables fell to $70.6 million from $73.4 million; service and other increased to $50.6 million from $46.0 million.
- Direct sales increased to $221.4 million from $205.1 million, while distributor sales declined to $89.6 million from $100.7 million.
Financial performance
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Gross profit / margin | $137.5 / 44.2% | $125.5 / 41.0% |
| Operating income / margin | $37.5 / 12.1% | $35.9 / 11.7% |
| Net income | $28.4 | $24.3 |
| Diluted EPS | $1.49 | $1.30 |
| Operating cash flow | $2.9 | $31.1 |
| Capital expenditures | $3.0 | $6.8 |
Gross margin expanded 320 basis points, attributed to pricing, cost-saving initiatives and a mix shift toward higher-margin industrial equipment and direct sales. S&A expense increased $8.2 million to $89.9 million, driven mainly by annualized growth resources and enterprise initiatives; R&D rose to $10.1 million from $7.9 million. The effective tax rate decreased to 19.1% from 24.1%, primarily due to discrete share-based compensation tax benefits. Net interest expense fell to $2.3 million from $3.7 million as average borrowings declined, despite a higher average interest rate.
Liquidity, debt and cash flows
Cash and restricted cash was $88.8 million at quarter-end, down from $117.1 million at December 31, 2023. Current assets were $561.1 million and current liabilities $260.4 million; the reported current ratio was 2.2. Total debt was $214.6 million, including $125.0 million of revolver borrowings and $88.8 million of term loans. The company reported $321.8 million of unused revolving capacity and a 25.8% debt-to-capital ratio. Weighted-average debt cost was approximately 6.5%, or 5.1% net of specified swap instruments.
Operating cash flow fell to $2.9 million, with working-capital use—particularly bonus payments and ERP modernization spending—partly offset by operating performance. Investing outflows were $60.6 million, mainly reflecting the Brain Corp investment ($32.1 million) and TCS acquisition payments net of cash acquired ($25.5 million). Financing provided $26.9 million, including net borrowings and stock-option exercise proceeds; dividends paid were $5.3 million.
Material changes, outlook and risks
- On February 29, Tennant acquired TCS, its largest Central and Eastern Europe distributor, to expand its EMEA direct channel. The acquisition contributed $2.1 million of quarterly revenue and immaterial net income; purchase-price allocation remains preliminary.
- On February 21, Tennant invested $32.1 million in Brain Corp securities to support development and adoption of robotics and AI technologies. The securities include Level 3 investments; no remeasurement was recorded by March 31.
- Backlog declined to $136.7 million from $186.2 million at year-end as component availability improved and production increased. Orders may be cancelled or postponed without penalty.
- Management expressed confidence in long-term market growth but gave no specific numerical financial guidance in the provided filing text. It cited economic uncertainty, skilled-labor availability, targeted supply-chain disruptions, regulation, inflation and geopolitical risks.
- Other stated risks include demand sensitivity to customer capital spending, pricing and competition, component availability and cost, product quality and liability, acquisition integration, personnel, IT modernization and cybersecurity. Management did not expect ordinary-course litigation and other claims to materially affect results or financial position.
Important facts for investors to verify
- Whether sales volumes and EMEA performance recover, and whether improved supply conditions continue to reduce backlog.
- How pricing, cost savings and product/channel mix affect margins as S&A and R&D spending increase.
- Cash conversion and working-capital trends following the Q1 operating cash-flow decline.
- Final TCS purchase-price allocation and the performance and valuation of the Brain Corp investment.
- Debt, borrowing costs, covenant compliance and availability under the revolving facility; the filing describes leverage and interest-coverage covenants.